GlassScriptPhysician profile
Andrew David Lonabaugh
NPI 1275965337
$11,408.54
in general payments reported to CMS, 2019-2025
32 companies · $6,964 in 2025
The $6,964 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $518 · 2021: $335 · 2022: $872 · 2023: $1,192 · 2024: $768 · 2025: $6,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,063 · Food and Beverage: $3,176 · Travel and Lodging: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,062.50 |
| Food and Beverage | $3,175.52 |
| Travel and Lodging | $685.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $6,787.93 | 2022-2025 | |
| Stryker Corporation | $1,399.22 | 2020-2025 | Prophecy, Variax, Citrefix |
| Wright Medical Technology, INC. | $1,054.63 | 2019-2020 | |
| Next Science LLC | $383.30 | 2023-2024 | Blastx, Xperience, Surgx |
| Biocomposites INC | $339.26 | 2021-2024 | Stimulan |
| Arthrex, INC. | $258.08 | 2023 | |
| Smith+Nephew, INC. | $184.05 | 2021-2024 | Collagenase Santyl, Grafix Pl, Regranex |
| Kerecis Limited | $119.44 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Embody, INC. | $114.12 | 2022 | |
| Paratek Pharmaceuticals, INC. | $78.55 | 2023-2025 | Nuzyra |
| Djo, LLC | $76.65 | 2019-2024 | Cmf |
| Southern Edge Orthopaedics, INC. | $73.86 | 2024-2025 | |
| Melinta Therapeutics, LLC | $55.38 | 2019 | |
| Curonix LLC | $43.26 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $41.95 | 2019-2024 | Exogen Ultrasound Bone Healing System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $38.17 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $37.57 | 2019-2022 | |
| Depuy Synthes Sales INC. | $35.63 | 2019 | |
| Orthofix Medical, INC. | $30.38 | 2020-2023 | Physio-Stim |
| Advanced Oxygen Therapy INC. | $29.01 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Medtronic, INC. | $28.17 | 2025 | Intellis Adaptivestim |
| Ibsa Pharma INC. | $23.35 | 2023 | Tirosint, Licart |
| Ebi, LLC | $21.85 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $21.85 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Celularity INC. | $21.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.88 | 2023 | Seglentis |
| Urgo Medical North America, LLC | $18.80 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Nevro Corp. | $18.10 | 2022 | |
| Mimedx Group, INC. | $15.70 | 2024 | |
| Kci USA, INC. | $15.17 | 2021 | |
| Ermi LLC | $12.86 | 2025 | |
| Acell, INC. | $12.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lonabaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.